ื”ืขื“ืคืชื›ื ืขื•ื“ื›ื ื” ืขื‘ื•ืจ ื”ืžืคื’ืฉ ื”ื–ื”. ื›ื“ื™ ืœืฉื ื•ืช ืืช ื”ื’ื“ืจืช ื”ื—ืฉื‘ื•ืŸ ืœืฆืžื™ืชื•ืช, ืขื‘ืจื• ืืœ
ืœื”ื–ื›ื™ืจื›ื, ื ื™ืชืŸ ืœืขื“ื›ืŸ ืืช ื”ืžื“ื™ื ื” ืื• ื”ืฉืคื” ื”ืžื•ืขื“ืคื•ืช ืขืœื™ื›ื ื‘ื›ืœ ืขืช ื‘
> beauty2 heart-circle sports-fitness food-nutrition herbs-supplements pageview
לחצו להצגת הצהרת הנגישות שלנו
משלוח חינם מעל ₪215.00
checkoutarrow

מדוע NAC וגלוטתיון חשובים לבריאות מערכת החיסון - ועוד

355,023 צפיות

anchor-icon תוכן העניינים dropdown-icon
anchor-icon תוכן העניינים dropdown-icon

N-ืืฆื˜ื™ืœ l-ืฆื™ืกื˜ืื™ืŸ (NAC) ื”ื•ื ื ื•ื’ื“ ื—ืžืฆื•ืŸ ืจื‘-ืขื•ืฆืžื” ืฉืžืงื•ืจื• ื‘ื—ื•ืžืฆืช ืืžื™ื ื• ื˜ื‘ืขื™ืช. ืจื•ืคืื™ื ืžืฉืชืžืฉื™ื ื‘ื• ืœืขืชื™ื ืงืจื•ื‘ื•ืช ืœื˜ื™ืคื•ืœ ื‘ืžื™ื ื•ืŸ ื™ืชืจ ืฉืœ ืคืจืฆื˜ืžื•ืœ (ืืฆื˜ืžื™ื ื•ืคืŸ, ืืงืžื•ืœ), ืื‘ืœ ื ืจืื” ื›ื™ ื™ืฉ ื™ืชืจื•ื ื•ืช ื‘ืจื™ืื•ืชื™ื™ื ื ื•ืกืคื™ื ื‘ืฉื™ืžื•ืฉ ื‘-NAC ื•/ืื• ื‘ืชื—ื™ืœืŸ ืฉืœื•,  ื’ืœื•ื˜ืชื™ื•ืŸ , ื‘ืชื•ืจ ืชื•ืกืฃ. ืื—ื“ ื”ืชื—ื•ืžื™ื ื”ืกืคืฆื™ืคื™ื™ื ืฉื‘ื”ื ื”ื—ื•ืงืจื™ื ืžื’ืœื™ื ืขื ื™ื™ืŸ ื”ื•ื ื”ืฉืคืขืช NAC ืขืœ ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ. 

ืœืื—ืจ ื ื˜ื™ืœืชื•, ื”ื’ื•ืฃ ื”ื•ืคืš ืืช NAC, ืฉื”ื•ื ื”ืชืจื›ื•ื‘ืช ื”ื™ืฆื™ื‘ื” ื™ื•ืชืจ, ืœืชืจื›ื•ื‘ืช ื™ืฆื™ื‘ื” ืคื—ื•ืช, ื’ืœื•ื˜ืชื™ื•ืŸ, ื”ืžื•ืจื›ื‘ ืžืฉืœื•ืฉ ื—ื•ืžืฆื•ืช ืืžื™ื ื•: ื’ืœื™ืฆื™ืŸ, ืฆื™ืกื˜ืื™ืŸ, ื•ื›ืŸ ื—ื•ืžืฆื” ื’ืœื•ื˜ืžื™ืช. ื’ืœื•ื˜ืชื™ื•ืŸ ืงื™ื™ื ื‘ืื•ืคืŸ ื˜ื‘ืขื™ ื‘ื‘ื ื™ ืื“ื, ื‘ื‘ืขืœื™ ื—ื™ื™ื, ื‘ืฆืžื—ื™ื ื•ื‘ืคื˜ืจื™ื•ืช, ื›ืืฉืจ ื”ื•ื ืขื•ื–ืจ ืœื”ื’ืŸ ืขืœ ื”ืชืื™ื ืžื ื–ืงื™ ื—ืžืฆื•ืŸ. ื ื•ืกืฃ ืขืœ ื›ืš, ื’ืœื•ื˜ืชื™ื•ืŸ ืขื•ื–ืจ ืœื’ื•ืฃ "ืœืžื—ื–ืจ" ื•ื™ื˜ืžื™ืŸ E ื•ื’ื ื•ื™ื˜ืžื™ืŸ C. ืžื—ืงืจื™ื ื”ืขืœื• ื›ื™ ืจืžื•ืช ื’ื‘ื•ื”ื•ืช ื™ื•ืชืจ ืฉืœ ื’ืœื•ื˜ืชื™ื•ืŸ ื ืงืฉืจื•ืช ืœื”ืคื—ืชืช ื”ืกื™ื›ื•ืŸ ืœืžื—ืœื•ืช, ื‘ืคืจื˜ ื‘ืžื‘ื•ื’ืจื™ื. 

ืื›ื™ืœืช ื”ืžื–ื•ื ื•ืช ื”ื‘ืื™ื ืฉืขืฉื™ืจื™ื ื‘ื’ื•ืคืจื™ืช ืขืฉื•ื™ื” ืœืขื–ื•ืจ ืœืžื˜ื‘ ืืช ืจืžืช ื”ื’ืœื•ื˜ืชื™ื•ืŸ ื‘ื“ื. ื›ืืฉืจ ื”ืชื–ื•ื ื” ืื™ื ื” ืžืกืคื™ืงื”, ื ื™ืชืŸ ืœืฉืงื•ืœ ืฉื™ืžื•ืฉ ื‘ืชื•ืกืฃ. 

ืคื™ืจื•ืช ื•ื™ืจืงื•ืช ืขืชื™ืจื™ ื’ื•ืคืจื™ืช:

  • ืื‘ื•ืงื“ื•
  • ื‘ืจื•ืงื•ืœื™
  • ื›ืจื•ื‘
  • ื›ืจื•ื‘ื™ืช
  • ืฉื•ื
  • ืืฉื›ื•ืœื™ื•ืช
  • ื›ืจื•ื‘ ืขืœื™ื
  • ื‘ืฆืœ
  • ืขื’ื‘ื ื™ื•ืช

ื’ื ืžื–ื•ื ื•ืช ืขืชื™ืจื™ ืฆื™ืกื˜ืื™ืŸ, ื›ืžื• ื‘ืฉืจ ืขื•ืฃ, ื”ื•ื“ื•, ื™ื•ื’ื•ืจื˜, ื’ื‘ื™ื ื”, ื‘ื™ืฆื™ื, ื–ืจืขื™ ื—ืžื ื™ื•ืช ื•ืงื˜ื ื™ื•ืช ื™ื›ื•ืœื™ื ืœืขื–ื•ืจ ืœื”ืขืœื•ืช ืืช ืจืžืช ื”ื’ืœื•ื˜ืชื™ื•ืŸ ื‘ื“ื. NAC ื”ื•ื ื”ืชื•ืกืฃ ื”ืชื–ื•ื ืชื™ ืฉื‘ื• ื‘ื“ืจืš ื›ืœืœ ืžืฉืชืžืฉื™ื ื›ื“ื™ ืœื”ืขืœื•ืช ืืช ืจืžื•ืช ื’ืœื•ื˜ืชื™ื•ืŸ. ื™ืฉ ื’ื ืื ืฉื™ื ืฉื‘ื•ื—ืจื™ื ืœื™ื˜ื•ืœ ืชื•ืกืฃ ื”ืžื›ื™ืœ ื’ืœื•ื˜ืชื™ื•ืŸ 

ืชื•ืžื›ื™ ื”ืฉื™ืžื•ืฉ ื‘ืชื•ืกืคื™ื ื”ืœืœื• ื˜ื•ืขื ื™ื ื›ื™ NAC/ื’ืœื•ื˜ืชื™ื•ืŸ ื™ื›ื•ืœื™ื ืœืขื–ื•ืจ ืœืžืขืจื›ื•ืช ื”ื‘ืื•ืช.

ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ ื•ื–ื™ื”ื•ืžื™ื

ื›ื“ื™ ืœื”ื™ืœื—ื ื‘ืคืชื•ื’ื ื™ื ื”ืžืกื•ื›ื ื™ื ืฉืืœื™ื”ื ืื ื—ื ื• ื—ืฉื•ืคื™ื ื‘ื—ื™ื™ ื”ื™ื•ืžื™ื•ื ืฉืœื ื•, ื›ื•ืœืœ ื ื’ื™ืคื™ื, ื—ื™ื™ื“ืงื™ื ื•ืคื˜ืจื™ื•ืช, ื ื“ืจืฉืช ืžืขืจื›ืช ื—ื™ืกื•ืŸ ื‘ืจื™ืื”. ืžื’ื•ื•ืŸ ื’ื•ืจืžื™ื ื”ืงืฉื•ืจื™ื ืœืื•ืจื— ื—ื™ื™ื, ืžืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ื•ื“ืคื•ืกื™ ืฉื™ื ื” ื•ืขื“ ืœืชื–ื•ื ื” ื•ื”ืชืžื•ื“ื“ื•ืช ืขื ืขืงื”, ื™ื›ื•ืœื™ื ืœื”ืฉืคื™ืข ืขืœ ื‘ืจื™ืื•ืช ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ, ื”ืŸ ืฉืœ ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ ื”ืžื•ืœื“ืช ื•ื”ืŸ ืฉืœ ื–ื• ื”ื ืจื›ืฉืช. 

ื™ืฉ ื’ื ืขื“ื•ื™ื•ืช ืœื›ืš ืฉื’ืœื•ื˜ืชื™ื•ืŸ ืขืฉื•ื™ ืœืžืœื ืชืคืงื™ื“ ื—ืฉื•ื‘ ื‘ืฉืžื™ืจื” ืขืœ ื‘ืจื™ืื•ืช ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ. ืžื—ืงืจื™ื ืžืฆื‘ื™ืขื™ื ืขืœ ื›ืš ืฉื’ืœื•ื˜ืชื™ื•ืŸ, ืืฉืจ ืžื™ื•ืฆืจ ื‘ืื•ืคืŸ ื˜ื‘ืขื™ ื‘ื›ื‘ื“, ื—ื™ื•ื ื™ ืœืฉืžื™ืจื” ืขืœ ืžื•ื›ื ื•ืช ืชืื™ ื”ื“ื ื”ืœื‘ื ื™ื, ื‘ืคืจื˜ ื”ืœื™ืžืคื•ืฆื™ื˜ื™ื, ืœื”ื™ืœื—ื ื‘ื–ื™ื”ื•ืžื™ื ื•ื‘ืžื—ืœื•ืช. 

ืžื—ืงืจ ืžืฉื ืช 2011 ื”ื“ื’ื™ื ื›ื™ ื”ืžื—ืœื•ืช ื”ื‘ืื•ืช ื ืงืฉืจื•ืช ืœืจืžื•ืช ื ืžื•ื›ื•ืช ื™ื•ืชืจ ืฉืœ ื’ืœื•ื˜ืชื™ื•ืŸ ื‘ื“ื.

  • ืคื’ื™ืขื” ืจื™ืืชื™ืช ื—ืจื™ืคื”/ืชืกืžื•ื ืช ืžืฆื•ืงื” ื ืฉื™ืžืชื™ืช ื—ืจื™ืคื”
  • ื‘ืจื•ื ื›ื™ื˜ื™ืก ื›ืจื•ื ื™ืช
  • ืžื—ืœืช ืจื™ืื•ืช ื—ืกื™ืžืชื™ืช ื›ืจื•ื ื™ืช
  • ืœื™ื™ืคืช ื›ื™ืกืชื™ืช (ืกื™ืกื˜ื™ืง ืคื™ื‘ืจื•ื–ื™ืก)
  • ืœื™ื™ืคืช ืจื™ืืชื™ืช ืจืืฉื•ื ื™ืช
  • ื–ื™ื”ื•ืžื™ื ื—ื™ื™ื“ืงื™ื™ื ื•ื ื’ื™ืคื™ื™ื ืฉื•ื ื™ื 

ืฆืจื™ื›ืช ืชื–ื•ื ื” ืขืชื™ืจืช ื’ื•ืคืจื™ืช ื•ืฆื™ืกื˜ืื™ืŸ ื™ื›ื•ืœื” ืœืขื–ื•ืจ ืœื”ื’ื‘ื™ืจ ืืช ืจืžืช ื”ื’ืœื•ื˜ืชื™ื•ืŸ ื‘ื’ื•ืฃ. ืื ื”ืชื–ื•ื ื” ืื™ื ื” ืžืกืคืงืช ื›ื“ื™ ืœื”ืขืœื•ืช ืืช ืจืžืช ื”ื’ืœื•ื˜ืชื™ื•ืŸ , ื ื™ืชืŸ ืœื™ื˜ื•ืœ ืื•ืชื• ื‘ืชื•ืกืฃ. 

ื‘ืจื™ืื•ืช ืžืขืจื›ืช ื”ื ืฉื™ืžื”

ืžื—ืœืช ืจื™ืื•ืช ื—ืกื™ืžืชื™ืช ื›ืจื•ื ื™ืช (COPD), ื”ื›ื•ืœืœืช ื ืคื—ืช ื•ื“ืœืงืช ืกื™ืžืคื•ื ื•ืช ื›ืจื•ื ื™ืช, ื”ื™ื ืžื—ืœื” ื ืฉื™ืžืชื™ืช ื ืคื•ืฆื” ืฉื‘ื“ืจืš ื›ืœืœ ื ื’ืจืžืช ืขืœ-ื™ื“ื™ ืขื™ืฉื•ืŸ. ืืžื ื ืชืจื•ืคื•ืช ืขื•ื–ืจื•ืช ืœื”ืงืœ ืขืœ ื”ื ืฉื™ืžื” ืฉืœ ืžื™ ืฉืกื•ื‘ืœ ืžืžื—ืœืช ื”ืจื™ืื•ืช ื”ื“ืœืงืชื™ืช ื”ื–ื•, ืื‘ืœ ืจื‘ื™ื ืขื“ื™ื™ืŸ ืžืขื“ื™ืคื™ื ื’ื™ืฉื•ืช ื˜ื‘ืขื™ื•ืช ื™ื•ืชืจ. 

ืœืขืชื™ื ืงืจื•ื‘ื•ืช ืื ืฉื™ื ืžืฉืชืžืฉื™ื ื‘ืชืจื•ืคื•ืช ืžืจืฉื ื‘ื ื•ืกืฃ ืœืชื•ืกืฃ ื›ืžื• NAC, ืฉื”ื•ื ืื—ื“ ื”ืชื•ืกืคื™ื ื”ื ืคื•ืฆื™ื ื‘ื™ื•ืชืจ. ื ื™ืชืŸ ืœื™ื˜ื•ืœ ืืช NAC ื‘ืชื•ืจ ืชื•ืกืฃ ืคื•ืžื™, ืื‘ืœ ื‘ื‘ืชื™ ืžืจืงื—ืช ืžื™ื•ื—ื“ื™ื ืžื›ื™ื ื™ื ื’ื ืชืžื™ืกื” ืคื•ืžื™ืช ื”ืžื™ื•ืขื“ืช ืœืฉื™ืžื•ืฉ ื‘ืืžืฆืขื•ืช ืžื›ืฉื™ืจ ืื™ื ื”ืœืฆื™ื”.

ืžื—ืงืจ ืžืฉื ืช 2012 ื”ื“ื’ื™ื ื›ื™ NAC ืขืฉื•ื™ ืœืขื–ื•ืจ ืœืคืจืง ืขื•ื“ืคื™ ืจื™ืจ ืฉืขืœื•ืœื™ื ืœื”ื™ื•ื•ืฆืจ ื‘ืจื™ืื•ืช ืฉืœ ื—ื•ืœื™ื, ื•ืื™ืœื• ืžื—ืงืจ ืžืฉื ืช 2013 ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช Chest ื’ื ื”ื“ื’ื™ืื›ื™ ืชื•ืก ื–ื” ืขืฉื•ื™ ืœื”ื•ืขื™ืœ ืœื—ื•ืœื™ COPD. ืžื—ืงืจ ืžืฉื ืช 2016 ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช Respiratory Medicine ื”ื’ื™ืข ืœืžืกืงื ื” ื›ื™ "ื™ืฉ ืœ-NAC ืชื›ื•ื ื•ืช ืื ื˜ื™-ื‘ืงื˜ืจื™ืืœื™ื•ืช ืžืจืฉื™ืžื•ืช, ืœืฆื“ ื”ื™ื›ื•ืœืช ืœืฉื‘ืฉ ื™ื™ืฆื•ืจ ื‘ื™ื•ืคื™ืœื ื•ืœืคืจืง ื‘ื™ื•ืคื™ืœื." ืขื ื–ืืช, ื”ื—ื•ืงืจื™ื ืงื‘ืขื• ืฉื ื“ืจืฉื™ื ืžื—ืงืจื™ื ื ื•ืกืคื™ื ื‘ื ื•ืฉื ื”ื–ื”. 

ืžื—ืงืจ ืžืฉื ืช 2014 ื“ืŸ ื‘ืขื“ื•ื™ื•ืช ืœื›ืš ืฉ-NAC ืขื•ื–ืจ ืœืฆืžืฆื ืืช ืชื“ื™ืจื•ืช ื”ื”ื—ืžืจื•ืช ืฉืœ COPD ื•ืœืฉืคืจ ืืช ื”ืชืคืงื•ื“ ืฉืœ ื“ืจื›ื™ ื”ื ืฉื™ืžื” ื”ืงื˜ื ื•ืช. ืžื—ืงืจ ืžืฉื ืช 2016 ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช Expert Review of Respiratory Medicine ืกื™ื›ื ื›ื™ NAC ื‘ืžื™ื ื•ืŸ ืฉืœ ื™ื•ืชืจ ืž-1,200 ืž"ื’ ื‘ื™ื•ื ืขืฉื•ื™ ืœืขื–ื•ืจ ืœืžื ื•ืข ื”ืชืœืงื—ื•ื™ื•ืช ื—ืจื™ืคื•ืช ืฉืœ COPD, ื•ื–ื” ื—ืฉื•ื‘ ื›ื™ ื—ื•ืœื™ื ืจื‘ื™ื ืฉืกื•ื‘ืœื™ื ืžืžื—ืœืช ืจื™ืื•ืช ื—ืกื™ืžืชื™ืช ื›ืจื•ื ื™ืช ืžื’ื™ืขื™ื ืœืืฉืคื•ื– ื‘ื’ืœืœ ื”ืชืœืงื—ื•ื™ื•ืช ื”ืžื—ืœื”. ื”ื—ื•ืงืจื™ื ื’ื ืงื‘ืขื• ื›ื™ ืžื™ื ื•ืŸ ืฉืœ 600 ืž"ื’ ื‘ื™ื•ื ืžืกืคื™ืง ื›ื“ื™ ืœื™ื™ืฆื‘ ื—ื•ืœื™ื ืขื ื‘ืจื•ื ื›ื™ื˜ื™ืก ื›ืจื•ื ื™ืช. 

ืขื ื–ืืช, ืžื—ืงืจื™ื ืฉื ืขืจื›ื• ื‘ืฉื ื™ื 2015 ื•-2017 ืœื ื”ื“ื’ื™ืžื• ืชื•ืขืœืช ืžืฉืžืขื•ืชื™ืช ืœืฉื™ืžื•ืฉ ื‘-NAC ื‘ื ื˜ื™ืœื” ืคื•ืžื™ืช ืื• ื‘ืืžืฆืขื•ืช ืื™ื ื”ืœืฆื™ื” ืืฆืœ ื—ื•ืœื™ื ืขื ืžื—ืœื•ืช ืจื™ืื•ืช. ืœื ื“ื•ื•ื— ืขืœ ื ื–ืงื™ื ื›ืœืฉื”ื, ืœื›ืŸ ืžื™ ืฉืžืขื•ื ื™ื™ืŸ ืœื ืกื•ืช ืœื”ืฉืชืžืฉ ื‘-NAC ื™ื›ื•ืœ ืœืขืฉื•ืช ื–ืืช ื‘ื‘ื˜ื—ื”. ื”ื”ืžืœืฆื” ืฉืœื™ ื”ื™ื ืฉืื ืชื‘ื—ื™ื ื• ื‘ืฉื™ืคื•ืจ, ื”ืžืฉื™ื›ื• ืœื™ื˜ื•ืœ ืืช ื”ืชื•ืกืฃ ื”ื–ื”. ืื ืื™ืŸ ืœื• ืชื•ืขืœืช, ืคืฉื•ื˜ ื”ืคืกื™ืงื• ืœื”ืฉืชืžืฉ ื‘ื•. 

ื‘ืจื™ืื•ืช ื”ื›ื‘ื“

ื”ื›ื‘ื“ ื”ื•ื ืžืกื ืŸ ื”ื“ื ื”ืขื™ืงืจื™ ื‘ื’ื•ืฃ, ื•ื”ื•ื ืื—ืจืื™ ืœืกื™ืœื•ืง ื›ื™ืžื™ืงืœื™ื ืฉืขืœื•ืœื™ื ืœื”ื™ื•ืช ืžืกื•ื›ื ื™ื (ื—ื•ืžืจื™ ื”ื“ื‘ืจื”, ืืœื›ื•ื”ื•ืœ, ืชืจื•ืคื•ืช ื•ืขื•ื“) ืžื”ื“ื. NAC ืขื•ื–ืจ ืœื”ื’ืŸ ืขืœ ื”ื›ื‘ื“ ืžืคื ื™ ืจืขืœื ื™ื, ื›ืžื• ืคืจืฆื˜ืžื•ืœ (ืืฆื˜ืžื™ื ื•ืคืŸ), ืืœื›ื•ื”ื•ืœ ื•ื›ื™ืžื™ืงืœื™ื ืกื‘ื™ื‘ืชื™ื™ื ืื—ืจื™ื. ื”ื•ื ื’ื ืขื•ื–ืจ ืœื’ื•ืฃ ืœื”ืขืœื•ืช ืืช ืจืžืช ื”ื’ืœื•ื˜ืชื™ื•ืŸ ื‘ืชืื™ื, ืžื” ืฉืžืืคืฉืจ ืœื›ื‘ื“ ืœืกืœืง ืืช ื”ื›ื™ืžื™ืงืœื™ื.

ืื ืฉื™ื ืฉืžืฉืชืžืฉื™ื ื‘ืคืจืฆื˜ืžื•ืœ (ืืฆื˜ืžื™ื ื•ืคืŸ, ืืงืžื•ืœ) ื‘ืื•ืคืŸ ืงื‘ื•ืข ืœืฉื™ื›ื•ืš ื›ืื‘ื™ื ื›ืจื•ื ื™ื™ื, ืฆืจื™ื›ื™ื ืœื”ื™ื•ืช ืžื•ื“ืขื™ื ืœื›ืš ืฉืฉื™ืžื•ืฉ ืงื‘ื•ืข ื‘ืชืจื•ืคื” ื”ื–ื• ืขืœื•ืœ ืœื”ื›ื‘ื™ื“ ืขืœ ื”ื›ื‘ื“ ื•ืœื”ื•ืจื™ื“ ืืช ืจืžื•ืช ื”ื’ืœื•ื˜ืชื™ื•ืŸ ื‘ื’ื•ืฃ. ืœืคื™ ื“ืขืชื™, ื›ื“ืื™ ืœืฉืงื•ืœ ืฉื™ืžื•ืฉ ื‘ืชื•ืกืฃ NAC, ืื• N-ืืฆื˜ื™ืœ-ืฆื™ืกื˜ืื™ืŸ, ื›ื“ื™ ืœืขื–ื•ืจ ืœืฆืžืฆื ืืช ื”ืขื•ืžืก ืขืœ ื”ื›ื‘ื“.

ื‘ืจื™ืื•ืช ื”ืœื‘

ืžื—ืœื•ืช ืœื‘ ื”ืŸ ื’ื•ืจื ื”ืชืžื•ืชื” ื”ืžื•ื‘ื™ืœ ื‘ืืจื”"ื‘, ื‘ืื™ืจื•ืคื” ื•ื‘ืืกื™ื”. ืœืžืจื‘ื” ื”ืฆืขืจ, ื›ื›ืœ ืฉืžื“ื™ื ื•ืช ื ื•ืกืคื•ืช ืžืืžืฆื•ืช ืืช ืื•ืจื—ื•ืช ื”ื—ื™ื™ื ืฉืœ ื”ืžืขืจื‘, ื‘ืžืงื•ื ื”ืชื–ื•ื ื” ื”ืžืกื•ืจืชื™ืช ืฉืœ ื”ืื‘ื•ืช ื”ืงื“ืžื•ื ื™ื, ื”ืฉื›ื™ื—ื•ืช ืฉืœ ืžื—ืœื•ืช ื”ืœื‘ ืชืžืฉื™ืš ืœืขืœื•ืช. ืจืง ื‘ืืจืฆื•ืช ื”ื‘ืจื™ืช ืžื—ืœื•ืช ืœื‘ ื•ื›ืœื™ ื“ื ื’ื•ืจืžื•ืช ืœื›ืžืขื˜ ืžื™ืœื™ื•ืŸ ืžืงืจื™ ืžื•ื•ืช ืžื™ื•ืชืจื™ื ื‘ื›ืœ ืฉื ื”. ืžื—ืœื•ืช ืœื‘ ื’ื•ืจืžื•ืช ืœื”ืชืงืคื™ ืœื‘ ื•ื‘ื”ืชืื ืœื–ืืช ื’ื ืœืคื’ื™ืขื” ื‘ืœื‘. 

ื’ื ืกื•ื›ืจืช ื•ืจืžื•ืช ืกื•ื›ืจ ื’ื‘ื•ื”ื•ืช ื‘ื“ื ืขืœื•ืœื•ืช ืœืคื’ื•ืข ื‘ืœื‘ ื•ืœื”ืขืœื•ืช ืืช ื”ืกื™ื›ื•ืŸ ืœื”ืชืงืฃ ืœื‘. ืžื—ืงืจ ืžืฉื ืช 2016 ืฉื ืขืจืš ื‘ืขื›ื‘ืจื•ืฉื™ื ื”ื“ื’ื™ื ืฆืžืฆื•ื ืฉืœ "ื”ืคื’ื™ืขื” ื”ื ื’ืจืžืช ืขืœ-ื™ื“ื™ ืกื•ื›ืจ" ื‘ืจืงืžืช ื”ืœื‘ ื›ืืฉืจ ื ืชื ื• ืœื ื‘ื“ืงื™ื ืชื•ืกืคืช ืฉืœ NAC. ืžืžืฆื ื–ื” ืžืจืžื– ื›ื™ NAC ืขืฉื•ื™ ืœื”ื’ืŸ ืขืœ ื”ืœื‘ ืฉืœ ื—ื•ืœื™ ืกื•ื›ืจืช. 

ืžื—ืงืจ ืžืฉื ืช 2018 ืฉื‘ื•ืฆืข ื‘ืขื›ื‘ืจื•ืฉื™ื ื”ืจืื” ื›ื™ NAC ืขืฉื•ื™ ืœืฆืžืฆื ืืช ื”ืคื’ื™ืขื” ื‘ืœื‘ ื”ื ื’ืจืžืช ืขืœ-ื™ื“ื™ ืืกืคืงืช ื—ืžืฆืŸ ืœืงื•ื™ื”. ืžื—ืงืจ ืื—ืจ ืฉื ืขืจืš ื‘ืื•ืชื” ื”ืฉื ื” ื”ืจืื” ืฉื™ืฉ ืœ-NAC ืชื•ืขืœืช ื‘ื”ื’ื ื” ืขืœ ืจืงืžืช ื”ืœื‘ ืžืคื ื™ ื”ืชืงืคื™ ืœื‘. 

ื‘ืฉื ืช 2018 ื ืขืจืš ืžื—ืงืจ ื‘ื‘ื ื™ ืื“ื ืฉื‘ื“ืง ืžื˜ื•ืคืœื™ื ืขื ืœื‘ ืžื•ื’ื“ืœ, ื•ืœื™ืชืจ ื“ื™ื•ืง ืขื ืžื—ืœื” ื‘ืฉื ืงืจื“ื™ื•ืžื™ื•ืคืชื™ื” ื”ื™ืคืจื˜ืจื•ืคื™ืช (HCM). ื‘ืžื—ืงืจ ื›ืคื•ืœ ืกืžื™ื•ืช, ืืงืจืื™, ืžื•ืชืื ืžื’ื“ืจ ื•ืžื‘ื•ืงืจ ืคืœืฆื‘ื• ื–ื” ื”ื ื‘ื“ืงื™ื ืงื™ื‘ืœื• ื’ืœื•ืœืช ืคืœืฆื‘ื• ืื• NAC ื‘ืžื™ื ื•ืŸ 2,400 ืž"ื’ ื‘ื™ื•ื. ื”ืžื—ืงืจ ื ืžืฉืš 12 ื—ื•ื“ืฉื™ื, ื›ืืฉืจ 29 ืžื”ื ื‘ื“ืงื™ื ืงื™ื‘ืœื• NAC ื•ืื™ืœื• 13 ืฉื•ื‘ืฆื• ืœืงื‘ื•ืฆืช ื”ืคืœืฆื‘ื•. ื”ื—ื•ืงืจื™ื ื”ื’ื™ืขื• ืœืžืกืงื ื” ืฉื”ื™ื” ืฉื™ืคื•ืจ ืงืœ, ืื‘ืœ ืœื ื ื™ืชืŸ ืœื”ื’ื™ืข ืœืžืกืงื ื•ืช ื—ื“-ืžืฉืžืขื™ื•ืช ื‘ื’ืœืœ ืžืกืคืจ ื”ืžืฉืชืชืคื™ื ื”ืžื•ื’ื‘ืœ ื‘ืžื—ืงืจ. 

ืžื—ืงืจ ืžืฉื ืช 2019 ื”ื“ื’ื™ื ื›ื™ NAC ืขืฉื•ื™ ืœืขื–ื•ืจ ืœื”ื’ืŸ ืขืœ ื”ืœื‘ ืฉืœ ืขื›ื‘ืจื•ืฉื™ื ืžืชื•ืคืขื•ืช ื”ืœื•ื•ืื™ ืฉืœ ืชืจื•ืคื•ืช ื›ื™ืžื•ืชืจืคื™ื•ืช ื”ืžืฉืžืฉื•ืช ืœื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ. ื—ืฉื•ื‘: ืื ืืชื ืžืงื‘ืœื™ื ื˜ื™ืคื•ืœ ื ื’ื“ ืกืจื˜ืŸ, ื—ืฉื•ื‘ ืžืื•ื“ ืœื”ืชื™ื™ืขืฅ ืขื ื”ืจื•ืคื ื”ืžื˜ืคืœ ืœืคื ื™ ืฉื™ืžื•ืฉ ื‘ืชื•ืกืคื™ื ื›ืœืฉื”ื. 

ื‘ืจื™ืื•ืช ื ืคืฉื™ืช

ื”ืคืจืขื•ืช ื ืคืฉื™ื•ืช ื›ืžื• ื—ืจื“ื”, ื“ื™ื›ืื•ืŸ ื•ืกื›ื™ื–ื•ืคืจื ื™ื” ืžื”ื•ื•ืช ืืชื’ืจ ื’ื ืœื—ื•ืœื™ื, ื’ื ืœืžืฉืคื—ื•ืช ื•ื’ื ืœืงื”ื™ืœื•ืช ืฉืœืžื•ืช. ื™ืฉ ื—ืฉื™ื‘ื•ืช ื—ื™ื•ื ื™ืช ืœืชื–ื•ื ื” ื•ืœืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ื›ื“ื™ ืœื”ื‘ื˜ื™ื— ื‘ืจื™ืื•ืช ื ืคืฉื™ืช ื•ื›ืœืœื™ืช ืžื™ื˜ื‘ื™ืช, ื•ืœืขืชื™ื ืงืจื•ื‘ื•ืช ืจื•ืคืื™ื ืจื•ืฉืžื™ื ืชืจื•ืคื•ืช ืฉืขื•ื–ืจื•ืช ืœื˜ืคืœ ื‘ื—ื•ืกืจ ืื™ื–ื•ืŸ ื›ื™ืžื™ ื‘ืžื•ื—. ืœืขืชื™ื ืงืจื•ื‘ื•ืช ื”ืชืจื•ืคื•ืช ื”ืœืœื• ืžื•ืขื™ืœื•ืช. ืขื ื–ืืช, ืจื‘ื™ื ืœื ื ื•ื˜ืœื™ื ืืช ื”ืชืจื•ืคื•ืช ืฉื ืจืฉืžื• ืขืœ-ื™ื“ื™ ืจื•ืคื ื‘ื’ืœืœ ื—ืฉืฉ ืžืคื ื™ ืชื•ืคืขื•ืช ืœื•ื•ืื™. ื‘ืžืงืจื™ื ืจื‘ื™ื ืื ืฉื™ื ืžื—ืคืฉื™ื ืคืชืจื•ื ื•ืช ื˜ื‘ืขื™ื™ื, ื•-NAC ื”ื•ื ืื—ื“ ื”ืคืชืจื•ื ื•ืช ื”ืคื•ืคื•ืœืจื™ื™ื. ื™ื™ืชื›ืŸ ืฉื™ืฉ ืœื• ืชื•ืขืœืช.

ืžื—ืงืจ ืžืฉื ืช 2018 ื”ื“ื’ื™ื ื›ื™ NAC ืขืฉื•ื™ ืœืขื–ื•ืจ ืœื˜ืคืœ ื‘ืื ืฉื™ื ื”ืกื•ื‘ืœื™ื ืžื”ืคืจืขื” ื“ื•-ืงื•ื˜ื‘ื™ืช, ื•ืื™ืœื• ืžื—ืงืจ ืžืฉื ืช 2016 ื”ืขืœื” ื›ื™ NAC ืขืฉื•ื™ ืœืขื–ื•ืจ ื›ืืฉืจ ื ื•ื˜ืœื™ื ืื•ืชื• ื‘ื ื•ืกืฃ ืœืชืจื•ืคื•ืช ื”ืจื’ื™ืœื•ืช ืœื˜ื™ืคื•ืœ ื‘ืกื›ื™ื–ื•ืคืจื ื™ื”. 

ื‘ืฉื ืช 2018 ื ืขืจืš ืžื—ืงืจ ืื—ืจ ืฉื‘ื“ืง ืžื˜ื•ืคืœื™ื ืขื ืกื›ื™ื–ื•ืคืจื ื™ื”. ื–ื” ื”ื™ื” ืžื—ืงืจ ืงืœื™ื ื™ ื›ืคื•ืœ ืกืžื™ื•ืช, ืืงืจืื™ ื•ืžื‘ื•ืงืจ ืคืœืฆื‘ื• ืฉื ืžืฉืš 12 ืฉื‘ื•ืขื•ืช. ืžื˜ืจืชื• ื”ื™ื™ืชื” ืœื”ืขืจื™ืš ืืช ื”ื™ืขื™ืœื•ืช ืฉืœ N-ืืฆื˜ื™ืœ-ืฆื™ืกื˜ืื™ืŸ (NAC) ื‘ืžื™ื ื•ืŸ 1,200 ืž"ื’ ืœืขื•ืžืช ืคืœืฆื‘ื•, ื‘ืชื•ืจ ืชื•ืกืคืช ืœื˜ื™ืคื•ืœ ืชืจื•ืคืชื™ ืงื•ื ื‘ื ืฆื™ื•ื ืœื™ ื‘ืกื›ื™ื–ื•ืคืจื ื™ื”. ื”ืฉืชืชืคื• ื‘ืžื—ืงืจ 84 ืžื˜ื•ืคืœื™ื ืขื ืกื›ื™ื–ื•ืคืจื ื™ื” ื›ืจื•ื ื™ืช. ื ืฆืคื” ืฉื™ืคื•ืจ ื›ืœืœื™ ื‘ื ื‘ื“ืงื™ื ืฉืงื™ื‘ืœื• NAC ื‘ื”ืฉื•ื•ืื” ืœืืœื” ืฉืงื™ื‘ืœื• ืคืœืฆื‘ื•. 

ืžื—ืงืจ ืžืฉื ืช 2017 ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช Psychological Medicine ื”ื’ื™ืข ืœืžืกืงื ื” ื›ื™ "ื™ื™ืชื›ืŸ ืฉื™ืฉ ืœ-NAC ื”ืฉืคืขื” ืขืœ ื”ืชืคืงื•ื“ ื”ืงื•ื’ื ื™ื˜ื™ื‘ื™ ื‘ืžืฆื‘ื™ ืคืกื™ื›ื•ื–ื”, ืฉื›ืŸ ื ืฆืคื” ืฉื™ืคื•ืจ ื ื™ื›ืจ ื‘ื–ื™ื›ืจื•ืŸ ืขื‘ื•ื“ื” ื‘ืงื‘ื•ืฆืช ื”ื ื‘ื“ืงื™ื ืฉืงื™ื‘ืœื” NAC, ื‘ื”ืฉื•ื•ืื” ืœืงื‘ื•ืฆืช ื”ืคืœืฆื‘ื•".

ืคื•ืจื™ื•ืช

ื‘ืขื™ื•ืช ืคื•ืจื™ื•ืช ื”ืŸ ื‘ืขื™ื•ืช ื ืคื•ืฆื•ืช ืฉืžื”ืŸ ืกื•ื‘ืœื™ื ืขืฉืจื•ืช ืžื™ืœื™ื•ื ื™ ืื ืฉื™ื ื‘ื›ืœ ืจื—ื‘ื™ ื”ืขื•ืœื. ื™ืฉ ืœื›ืš ืกื™ื‘ื•ืช ืจื‘ื•ืช, ื•ื™ืฉ ื’ื ื’ื‘ืจื™ื ื•ื’ื ื ืฉื™ื ืฉืกื•ื‘ืœื™ื ืžื‘ืขื™ื•ืช ืคื•ืจื™ื•ืช. ื ืจืื” ืฉื™ืฉ ืœ-NAC ืชืคืงื™ื“ ื—ืฉื•ื‘ ื‘ืคื•ืจื™ื•ืช, ื‘ื’ืœืœ ื”ืฉืคืขืชื• ื ื’ื“ ื—ืžืฆื•ืŸ 

ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช (PCOS) ื”ื™ื ืกื™ื‘ื” ื ืคื•ืฆื” ืœืขืงืจื•ืช. ืœืžืจื‘ื” ื”ืžื–ืœ, ืœืขืชื™ื ืงืจื•ื‘ื•ืช ื”ืžื—ืœื” ื”ื–ื• ื ื’ืจืžืช ืขืœ-ื™ื“ื™ ืชื–ื•ื ื” ื•ืื•ืจื— ื—ื™ื™ื, ืœื›ืŸ ื‘ื™ืฆื•ืข ื”ืฉื™ื ื•ื™ื™ื ื”ื ื“ืจืฉื™ื ื‘ืชื–ื•ื ื” ื•ื‘ืื•ืจื— ื”ื—ื™ื™ื, ื›ื•ืœืœ ื™ืจื™ื“ื” ื‘ืžืฉืงืœ, ื™ื›ื•ืœ ืœืขื–ื•ืจ ืœื”ื™ื›ื ืก ืœื”ืจื™ื•ืŸ. ืขื ื–ืืช, ืœืคืขืžื™ื ื ื“ืจืฉ ืฉื™ืžื•ืฉ ื‘ืชืจื•ืคื•ืช.

ืžื—ืงืจ ืžืฉื ืช 2017 ื”ื“ื’ื™ื ื›ื™ ื ื˜ื™ืœืช NAC ืœืฆื“ ืงืœื•ืžื™ืคืŸ, ืชืจื•ืคื” ืฉื‘ื” ืžืฉืชืžืฉื™ื ืœืขืชื™ื ืงืจื•ื‘ื•ืช ืœื˜ื™ืคื•ืœ ื‘ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช, ืขืฉื•ื™ ืœืขื–ื•ืจ ืœื ืฉื™ื ื”ืžืขื•ื ื™ื™ื ื•ืช ืœื”ื™ื›ื ืก ืœื”ืจื™ื•ืŸ. ื”ืขืจื”: ื—ืฉื•ื‘ ืชืžื™ื“ ืœื”ืชื™ื™ืขืฅ ืขื ื”ืจื•ืคื ื”ืžื˜ืคืœ ืœืคื ื™ ืชื—ื™ืœืช ืฉื™ืžื•ืฉ ื‘ืชื•ืกืคื™ื. 

ืžื—ืงืจ ืžืฉื ืช 2020 ื”ืฉื•ื•ื” ื‘ื™ืŸ NAC ืœืžื˜ืคื•ืจืžื™ืŸ, ืชืจื•ืคื” ืฉื‘ื” ืžืฉืชืžืฉื™ื ืœืขืชื™ื ืงืจื•ื‘ื•ืช ืœื˜ื™ืคื•ืœ ื‘ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช. ื”ืžื—ืงืจ ื”ืขืœื” ื›ื™ NAC ืœื ืจืง ืชืจื ืœื™ืจื™ื“ื” ื‘ืžืฉืงืœ, ืืœื ื’ื ื”ื•ืจื™ื“ ืืช ืจืžื•ืช ื”ื˜ืกื˜ื•ืกื˜ืจื•ืŸ ื‘ื ื‘ื“ืงื•ืช. ื”ื—ื•ืงืจื™ื ื”ื’ื™ืขื• ืœืžืกืงื ื” ื›ื™ ื ื™ืชืŸ ืœืฉืงื•ืœ ืฉื™ืžื•ืฉ ื‘-NAC ื›ื—ืœื•ืคื” ืœืžื˜ืคื•ืจืžื™ืŸ. ืฉื™ืขื•ืจื™ ื”ื”ืจื™ื•ืŸ ื”ื™ื• ื–ื”ื™ื ื‘ืฉืชื™ ื”ืงื‘ื•ืฆื•ืช.

ืžื—ืงืจ ืžืฉื ืช 2019 ื ื•ืชืŸ ืชืงื•ื•ื” ื’ื ืœื’ื‘ืจื™ื ืขื ืื™ื›ื•ืช ื–ืจืข ืชืช-ืžื™ื˜ื‘ื™ืช. ื‘ืžื—ืงืจ ื”ื–ื” ื ืฆืคื” ืฉื™ืคื•ืจ ื’ื ื‘ืกืคื™ืจืช ื”ื–ืจืข ื•ื’ื ื‘ื ื™ื™ื“ื•ืช ื”ื–ืจืขื•ื ื™ื, ื•ื”ื—ื•ืงืจื™ื ื”ื’ื™ืขื• ืœืžืกืงื ื” ื›ื™ "ื™ื™ืชื›ืŸ ืฉืชื•ืกืคืช ืฉืœ NAC 

ืขืฉื•ื™ื” ืœืฉืคืจ ืืช ืžื“ื“ื™ ื”ื–ืจืข ื•ืืช ื”ืžืื–ืŸ ื‘ื™ืŸ ื”ืขืงื” ื”ื—ืžืฆื•ื ื™ืช ืœืคืขื™ืœื•ืช ื ื’ื“ ื—ืžืฆื•ืŸ ื‘ื’ื‘ืจื™ื ืขืงืจื™ื."

ืื™ื–ื•ืŸ ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื

ื™ื•ืชืจ ืž-422 ืžื™ืœื™ื•ืŸ ืื ืฉื™ื ื‘ื›ืœ ืจื—ื‘ื™ ื”ืขื•ืœื ืกื•ื‘ืœื™ื ืžืกื•ื›ืจืช. ืจื•ื‘ื ื”ืžื›ืจื™ืข, ื‘ื™ืŸ 90 ืœ-95 ืื—ื•ื–, ืกื•ื‘ืœื™ื ืžืกื•ื›ืจืช ืกื•ื’ 2, ืžื—ืœื” ื”ื ื’ืจืžืช ื‘ืขื™ืงืจ ืขืœ-ื™ื“ื™ ื’ื•ืจืžื™ื ืฉืงืฉื•ืจื™ื ืœืื•ืจื— ื—ื™ื™ื, ื›ืžื• ืชื–ื•ื ื” ืœืงื•ื™ื” ื•ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืžื•ื’ื‘ืœืช. ืœื ื ื™ืชืŸ ืœื‘ืœื•ื ื”ืชืคืชื—ื•ืช ืฉืœ ืกื•ื›ืจืช ืกื•ื’ 1 ื‘ืจื’ืข ืฉื”ืžื—ืœื” ื”ื–ื• ืžืชื—ื™ืœื”. ื‘ืกื•ื›ืจืช ืกื•ื’ 1 ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ ืชื•ืงืคืช ืืช ื”ืœื‘ืœื‘ ื‘ื˜ืขื•ืช, ืžื” ืฉื’ื•ืจื ืœื›ืš ืฉื”ืœื‘ืœื‘ ืœื ื™ื›ื•ืœ ืœื™ื™ืฆืจ ืื™ื ืกื•ืœื™ืŸ. 

ืžื—ืงืจ ืžืฉื ืช 2018 ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช American Journal of Cardiovascular Drugs ื”ื“ื’ื™ื ื”ื’ื ื” ื˜ื•ื‘ื” ื™ื•ืชืจ ืขืœ ื”ืœื‘ ืฉืœ ื—ื•ืœื™ ืกื•ื›ืจืช ื‘ืงืจื‘ ื—ื•ืœื™ื ืฉืงื™ื‘ืœื• ืชื•ืกืคืช ืฉืœ NAC . ื‘ืคืจื˜, ื”ื—ื•ืงืจื™ื ื”ืขื™ืจื• ื›ื™ "NAC ืžื“ื’ื™ื ืคื•ื˜ื ืฆื™ืืœ ืžืฉืžืขื•ืชื™ ืœื”ื’ื ื” ืขืœ ืœื‘ื ืฉืœ ื—ื•ืœื™ ืกื•ื›ืจืช, ื‘ื–ื›ื•ืช ื”ืคื—ืชืช ื”ืกื™ื›ื•ืŸ ืœืื•ื˜ื ืฉืจื™ืจ ื”ืœื‘ ืขืœ-ื™ื“ื™ ืขื™ื›ื•ื‘ ืฉืœ ืขืงื” ื—ืžืฆื•ื ื™ืช..."

ืžืขื‘ืจ ืœื›ืš, ืžืืžืจ ืกืงื™ืจื” ืฉืคื•ืจืกื ื‘ืฉื ืช 2019 ื‘ื›ืชื‘ ื”ืขืช Pharmacological Research ื“ืŸ ื‘ืขื“ื•ื™ื•ืช ื”ืžืฆื‘ื™ืขื•ืช ืขืœ ื›ืš ืฉ-NAC ืขืฉื•ื™ ืœืฉืคืจ ืืช ื”ืจื’ื™ืฉื•ืช ืœืื™ื ืกื•ืœื™ืŸ ืืฆืœ ืื ืฉื™ื ืขื ืชื ื’ื•ื“ืช ืœืื™ื ืกื•ืœื™ืŸ, ื˜ืจื•ื-ืกื•ื›ืจืช ืื• ืกื•ื›ืจืช. 

ื’ื ืื ืฉื™ืžื•ืฉ ื‘ืชื•ืกืคื™ื ืœื˜ื™ืคื•ืœ ื‘ืกื•ื›ืจืช ืขืฉื•ื™ ืœื”ื•ืขื™ืœ ืœื—ื•ืœื™ ืกื•ื›ืจืช ืžืกื•ื™ืžื™ื, ืฉื™ื ื•ื™ื™ื ื‘ืจื™ืื™ื ื‘ืื•ืจื— ื”ื—ื™ื™ื ื”ื ื”ื‘ืกื™ืก ืœืื™ื–ื•ืŸ ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื.. ืืกื•ืจ ืœื—ื•ืœื™ ืกื•ื›ืจืช ืœื”ืคืกื™ืง ืœื™ื˜ื•ืœ ืืช ื”ื˜ื™ืคื•ืœ ื”ืชืจื•ืคืชื™ ื‘ืœื™ ืœื”ืชื™ื™ืขืฅ ืขื ื”ืจื•ืคื ื”ืžื˜ืคืœ ืงื•ื“ื.

ืกื™ืžื•ื›ื™ืŸ:

  1. Julius M, Lang CA, Gleiberman L, Harburg E, DiFranceisco W, Schork A. Glutathione and morbidity in a community-based sample of elderly. J Clin Epidemiol. 1994;47(9):1021โ€“1026. doi:10.1016/0895-4356(94)90117-1Drรถge W, Breitkreutz R. Glutathione and immune function. Proc Nutr Soc. 2000;59(4):595โ€“600. doi:10.1017/s0029665100000847
  2.  Ghezzi P. Role of glutathione in immunity and inflammation in the lung. Int J Gen Med. 2011;4:105โ€“113. Published 2011 Jan 25. doi:10.2147/IJGM.S15618Sadowska AM. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2012;6(3):127โ€“135. doi:10.1177/1753465812437563
  3.  Tse HN, Raiteri L, Wong KY, et al. High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study. Chest. 2013;144(1):106โ€“118. doi:10.1378/chest.12-2357
  4.  Santus P, Corsico A, Solidoro P, Braido F, Di Marco F, Scichilone N. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine. COPD. 2014;11(6):705โ€“717. doi:10.3109/15412555.2014.898040
  5.  Matera MG, Calzetta L, Cazzola M. Oxidation pathway and exacerbations in COPD: the role of NAC. Expert Rev Respir Med. 2016;10(1):89โ€“97. doi:10.1586/17476348.2016.1121105
  6.  Ayfer Aytemur Z, Baysak A, Ozdemir O, Kรถse T, Sayiner A. N-acetylcysteine in patients with COPD exacerbations associated with increased sputum. Wien Klin Wochenschr. 2015;127(7-8):256โ€“261. doi:10.1007/s00508-014-0692-4
  7.  Kalyuzhin OV. Effect of N-acetylcysteine on mucosal immunity of respiratory tract. Ter Arkh. 2018;90(3):89โ€“95. doi:10.26442/terarkh201890389-95
  8.  Fundam Clin Pharmacol. 2018 Nov 24. doi: 10.1111/fcp.12437. (NAC and Acetaminophen)
  9.  Fisher ES, Curry SC. Evaluation and treatment of acetaminophen toxicity. Adv Pharmacol. 2019;85:263โ€“272. doi:10.1016/bs.apha.2018.12.004
  10.  Su W, Zhang Y, Zhang Q, et al. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats. Cardiovasc Diabetol. 2016;15(1):146. Published 2016 Oct 12. doi:10.1186/s12933-016-0460-z
  11.  Bartekova M, Barancik M, Ferenczyova K, Dhalla NS. Beneficial Effects of N-acetylcysteine and N-mercaptopropionylglycine on Ischemia Reperfusion Injury in the Heart. Curr Med Chem. 2018;25(3):355โ€“366. doi:10.2174/0929867324666170608111917
  12. Zaki SM, Abdalla IL, Sadik AOE, Mohamed EA, Kaooh S. Protective Role of N-Acetylcysteine on Isoprenaline-Induced Myocardial Injury: Histological, Immunohistochemical and Morphometric Study. Cardiovasc Toxicol. 2018;18(1):9โ€“23. doi:10.1007/s12012-017-9407-1
  13. Marian AJ, Tan Y, Li L, et al. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study. Circ Res. 2018;122(8):1109โ€“1118. doi:10.1161/CIRCRESAHA.117.312647
  14.  Gunturk EE, Yucel B, Gunturk I, Yazici C, Yay A, Kose K. The effects of N-acetylcysteine on cisplatin induced cardiotoxicity. Bratisl Lek Listy. 2019;120(6):423โ€“428. doi:10.4149/BLL_2019_068
  15.  Bauer IE, Green C, Colpo GD, et al. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression. J Clin Psychiatry. 2018;80(1):18m12200. Published 2018 Dec 4. doi:10.4088/JCP.18m12200
  16. Miyake N, Miyamoto S. Nihon Shinkei Seishin Yakurigaku Zasshi. 2016;36(2):29โ€“35.
  17.  Rapado-Castro M, Dodd S, Bush AI, et al. Cognitive effects of adjunctive N-acetyl cysteine in psychosis. Psychol Med. 2017;47(5):866โ€“876. doi:10.1017/S0033291716002932
  18.  Adeoye O, Olawumi J, Opeyemi A, Christiania O. Review on the role of glutathione on oxidative stress and infertility. JBRA Assist Reprod. 2018;22(1):61โ€“66. Published 2018 Mar 1. doi:10.5935/1518-0557.20180003
  19.  Nemati M, Nemati S, Taheri AM, Heidari B. Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome. J Gynecol Obstet Hum Reprod. 2017;46(7):579โ€“585. doi:10.1016/j.jogoh.2017.07.004
  20.  Jannatifar R, Parivar K, Roodbari NH, Nasr-Esfahani MH. Effects of N-acetyl-cysteine supplementation on sperm quality, chromatin integrity and level of oxidative stress in infertile men. Reprod Biol Endocrinol. 2019;17(1):24. Published 2019 Feb 16. doi:10.1186/s12958-019-0468-9
  21. Dludla PV, Dias SC, Obonye N, Johnson R, Louw J, Nkambule BB. A Systematic Review on the Protective Effect of N-Acetyl Cysteine Against Diabetes-Associated Cardiovascular Complications. Am J Cardiovasc Drugs. 2018;18(4):283โ€“298. doi:10.1007/s40256-018-0275-2
  22. Dludla PV, Mazibuko-Mbeje SE, Nyambuya TM, et al. The beneficial effects of N-acetyl cysteine (NAC) against obesity associated complications: A systematic review of pre-clinical studies. Pharmacol Res. 2019;146:104332. doi:10.1016/j.phrs.2019.104332

โ€‹ื›ืชื‘ ื•ื™ืชื•ืจ:โ€‹ ืžืจื›ื– ื”ื‘ืจื™ืื•ืช ื”ื–ื” ืœื ื ื•ืขื“ ืœืื‘ื—ืŸ,,, โ€‹ื”ืฆื’ ืขื•ื“